Meta-Analysis
Copyright ©The Author(s) 2023.
World J Gastroenterol. May 28, 2023; 29(20): 3185-3202
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3185
Figure 1
Figure 1  PRISMA flow diagram for the literature search.
Figure 2
Figure 2  Risk of bias assessments for the trials reviewed.
Figure 3
Figure 3 Forest plot of randomised controlled trials of fecal microbiota transplantation for treating irritable bowel syndrome: Improvement of symptoms after three and six months. FMT: Fecal microbiota transplantation.
Figure 4
Figure 4 Forest plot of randomised controlled trials of fecal microbiota transplantation for treating irritable bowel syndrome: Adverse events. FMT: Fecal microbiota transplantation.
Figure 5
Figure 5  Forest plot of randomised controlled trials of fecal microbiota transplantation for treating irritable bowel syndrome: Quality-of-life scores after three and six months.
Figure 6
Figure 6 Forest plot of randomised controlled trials of fecal microbiota transplantation for treating irritable bowel syndrome: Improvement of symptoms after three and six months (route of administration subgroup analysis). FMT: Fecal microbiota transplantation.